Anolik JH - Search Results

1

Activated Peripheral Blood B Cells in Rheumatoid Arthritis and Their Relationship to Anti-Tumor Necrosis Factor Treatment and Response: A Randomized Clinical Trial of the Effects of Anti-Tumor Necrosis Factor on B Cells.

Meednu N, Barnard J, Callahan K, Coca A, Marston B, Thiele R, Tabechian D, Bolster M, Curtis J, Mackay M, Graf J, Keating R, Smith E, Boyle K, Keyes-Elstein L, Welch B, Goldmuntz E, Anolik JH. Meednu N, et al. Among authors: anolik jh. Arthritis Rheumatol. 2022 Feb;74(2):200-211. doi: 10.1002/art.41941. Epub 2021 Dec 27. Arthritis Rheumatol. 2022. PMID: 34347945 Free PMC article. Clinical Trial.

2

Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus.

Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, Sanz I. Anolik JH, et al. Arthritis Rheum. 2004 Nov;50(11):3580-90. doi: 10.1002/art.20592. Arthritis Rheum. 2004. PMID: 15529346 Free article. Clinical Trial.

3

Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus.

Cappione A 3rd, Anolik JH, Pugh-Bernard A, Barnard J, Dutcher P, Silverman G, Sanz I. Cappione A 3rd, et al. Among authors: anolik jh. J Clin Invest. 2005 Nov;115(11):3205-16. doi: 10.1172/JCI24179. Epub 2005 Oct 6. J Clin Invest. 2005. PMID: 16211091 Free PMC article.

4

Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy.

Anolik JH, Barnard J, Owen T, Zheng B, Kemshetti S, Looney RJ, Sanz I. Anolik JH, et al. Arthritis Rheum. 2007 Sep;56(9):3044-56. doi: 10.1002/art.22810. Arthritis Rheum. 2007. PMID: 17763423 Free article.

5

Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks.

Anolik JH, Ravikumar R, Barnard J, Owen T, Almudevar A, Milner EC, Miller CH, Dutcher PO, Hadley JA, Sanz I. Anolik JH, et al. J Immunol. 2008 Jan 15;180(2):688-92. doi: 10.4049/jimmunol.180.2.688. J Immunol. 2008. PMID: 18178805 Clinical Trial.

6

Targeted biologic approaches to the treatment of systemic vasculitis.

Coca A, Anolik JH. Coca A, et al. Among authors: anolik jh. Clin Rev Allergy Immunol. 2008 Oct;35(1-2):79-87. doi: 10.1007/s12016-007-8072-8. Clin Rev Allergy Immunol. 2008. PMID: 18181033 Review.

7

Novel human transitional B cell populations revealed by B cell depletion therapy.

Palanichamy A, Barnard J, Zheng B, Owen T, Quach T, Wei C, Looney RJ, Sanz I, Anolik JH. Palanichamy A, et al. Among authors: anolik jh. J Immunol. 2009 May 15;182(10):5982-93. doi: 10.4049/jimmunol.0801859. J Immunol. 2009. PMID: 19414749 Free PMC article.

8

B cells in the pathogenesis and treatment of rheumatoid arthritis.

Marston B, Palanichamy A, Anolik JH. Marston B, et al. Among authors: anolik jh. Curr Opin Rheumatol. 2010 May;22(3):307-15. doi: 10.1097/BOR.0b013e3283369cb8. Curr Opin Rheumatol. 2010. PMID: 20090526 Free PMC article. Review.

9

Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus.

Bekar KW, Owen T, Dunn R, Ichikawa T, Wang W, Wang R, Barnard J, Brady S, Nevarez S, Goldman BI, Kehry M, Anolik JH. Bekar KW, et al. Among authors: anolik jh. Arthritis Rheum. 2010 Aug;62(8):2443-57. doi: 10.1002/art.27515. Arthritis Rheum. 2010. PMID: 20506300 Free PMC article.

10

Two negative randomized controlled trials in lupus: now what?

Coca A, Anolik JH. Coca A, et al. Among authors: anolik jh. F1000 Med Rep. 2009 May 8;1:28. doi: 10.3410/M1-28. F1000 Med Rep. 2009. PMID: 20948753 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page